Related Experiment Videos
A five-amino-acid peptide blocks Met- and Ron-dependent cell migration
Alexandra Matzke1, Peter Herrlich, Helmut Ponta
1Forschungszentrum Karlsruhe, Institute of Toxicology and Genetics, Karlsruhe, Germany.
Cancer Research
|July 19, 2005
Summary
Specific amino acids in CD44 v6 act as coreceptors, essential for activating Met and Ron receptor tyrosine kinases in human cancers. Small peptides targeting these sites block cancer cell migration.
Area of Science:
- Molecular biology
- Cancer research
- Cell signaling
Background:
- Elevated levels of receptor tyrosine kinases Met and Ron are observed in various human cancers.
- CD44 v6-containing isoforms function as essential coreceptors for Met and Ron activation.
Purpose of the Study:
- To identify critical amino acids within the CD44 v6 sequence responsible for coreceptor function.
- To investigate the potential of targeting these amino acids to inhibit Met/Ron activation and cancer cell migration.
Main Methods:
- Mutational analysis of the CD44 v6 sequence to pinpoint essential amino acids.
- Synthesis and testing of peptides containing the identified critical amino acids.
- Assays to measure ligand-dependent activation of Met/Ron and subsequent cell migration.
Main Results:
- Three amino acids (EWQ in rat, RWH in human) within the CD44 v6 sequence were identified as essential for coreceptor function.
- Small peptides (as few as five amino acids) encompassing these critical residues effectively competed for coreceptor binding.
- These peptides blocked ligand-dependent activation of Met and Ron, consequently inhibiting cancer cell migration.
Conclusions:
- The identified amino acid motifs are crucial for CD44 v6 coreceptor activity in Met and Ron signaling.
- Targeting these specific motifs with peptide inhibitors presents a potential therapeutic strategy for cancers driven by Met/Ron activation.